Ninety One North America’s AbbVie ABBV Stock Holding History

Ninety One North America’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-58,066	Closed	-$7.86M	–	103
2021 Q4	$7.86M	Hold	58,066	–	–	0.28%	61
2021 Q3	$6.26M	Hold	58,066	–	–	0.29%	57
2021 Q2	$6.54M	Hold	58,066	–	–	0.31%	60
2021 Q1	$6.28M	Buy	58,066 +4,268	+8%	+$457K	0.36%	58
2020 Q4	$5.76M	Hold	53,798	–	–	0.35%	62
2020 Q3	$4.71M	Sell	53,798 -507	-0.9%	-$47.7K	0.52%	51
2020 Q2	$5.33M	Sell	54,305 -205,574	-79%	-$18.1M	0.55%	39
2020 Q1	$19.8M	Buy	259,879 +136,780	+111%	+$11.7M	1.64%	19
2019 Q4	$10.9M	Buy	+123,099	New	+$10.2M	0.89%	34

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ninety One North America's ABBV Position: Q1 2022 in Review

Ninety One North America sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 58,066 shares — an estimated $7.86M sold.

Ninety One North America first reported a position in ABBV in Q4 2019 and held it in 9 quarters. The position peaked at $19.8M in Q1 2020. 3,053 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

Ninety One North America reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
Ninety One North America sold 58,066 AbbVie shares in Q1 2022, an estimated $7.86M.
Ninety One North America first reported a position in AbbVie in Q4 2019 and held it in 9 quarters.
Ninety One North America's AbbVie position peaked at $19.8M in Q1 2020.
3,053 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Ninety One North America's 13F filing for Q1 2022, filed 27 Apr 2022.